About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,488 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,488 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4661-4680 of 22,488 trials

Active not recruitingProVee Urethral Expander System IDE Study (ProVIDE)A study to evaluate the safety, performance, and effectiveness of the ProVee Urethral Expander System (Investigational Device) when used in subjects with symptomatic urinary…NCT05186740·Sacramento, California and 15 others RecruitingImplementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)IRIS-CKD is a two-program implementation study to improve guideline-recommended screening and treatment of chronic kidney disease (CKD) in individuals with type 2 diabetes (T2D)…NCT06906640·Birmingham, Alabama and 6 others RecruitingA Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)The purpose of this study is to assess the efficacy and safety of opevesostat plus daily corticosteroids compared to alternative abiraterone acetate or enzalutamide in…NCT06136650·Tucson, Arizona and 329 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

TerminatedStudy Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)A Phase Ib/II, open-label, multicenter, randomized, umbrella study in participants with MIBC and in participants with locally advanced or metastatic Urothelial Carcinoma (UC) who…NCT03869190·Los Angeles, California and 32 others

CompletedEfficacy of the HCVIDDOXIL Regimen in Patients With Newly Diagnosed Peripheral T-Cell LymphomaThe goal of this clinical research study is to learn if treatment with two types of chemotherapy combinations can help to control peripheral T-cell lymphoma.NCT00290433·Houston, Texas

CompletedSafety of Intravenous Thrombolysis for Wake-up StrokeThe purpose is to demonstrate the safety of intravenous tissue plasminogen activator (IV t-PA) in ischemic stroke patients who present to the emergency department (ED) after…NCT01183533·Birmingham, Alabama and 2 others

Terminated68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine TumorsThis trial studies how well gallium Ga 68-edotreotide (68Ga-DOTA-TOC) positron emission tomography (PET)/computer tomography (CT) works in imaging participants with neuroendocrine…NCT03001349·Houston, Texas

CompletedLumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)This is an open label, Phase I/II, dose escalation research study of an investigational product called lumiliximab, given with FDA (Food and Drug Administration) approved products…NCT00103558·Birmingham, Alabama and 4 others

CompletedEfficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With GastroparesisTo evaluate the safety and the effectiveness of two doses of metoclopramide nasal spray solution, 10 mg and 14 mg, compared to placebo in reducing the symptoms of diabetic…NCT00845858·Dothan, Alabama and 64 others

WithdrawnHomoharringtonine in Treating Patients With Refractory Acute Promyelocytic LeukemiaRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00030355·Houston, Texas

CompletedTrivalent rHA Dose Escalation Study in Elderly SubjectsThis study will compare the safety and immunogenicity of three different dose levels of an experimental recombinant influenza HA protein vaccine to a standard inactivated…NCT00170443·Rochester, New York and 2 others

TerminatedVaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's LymphomaRATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00089115·Birmingham, Alabama and 59 others

Active not recruitingA Randomized, Double-blind 2-arm, Followed by an Open-label 1-arm, NEPTUNUS Extension Study to Assess the Long-term Safety and Efficacy of Ianalumab in Patients With Sjogrens Syndrome.The purpose of this study is to measure the long-term safety and tolerability of ianalumab in participants with Sjögren's syndrome who have previously completed treatment from one…NCT05985915·Fullerton, California and 197 others

TerminatedStudy of CYH33 in Combination With Olaparib an Oral PARP Inhibitor in Patients With Advanced Solid Tumors.The purpose of this study is to assess the safety, tolerability and preliminary efficacy of CYH33 in combination with olaprib in patients with DDR gene mutations and/or PIK3CA…NCT04586335·New Haven, Connecticut and 6 others

RecruitingExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)The primary objective of this trial is to evaluate the long-term efficacy, safety, and tolerability of maridebart cafraglutide in participants with obesity or overweight.NCT07684235·Anniston, Alabama and 91 others

CompletedEvaluate the Safety and Efficacy of 48-Hour Infusions of HNO (Nitroxyl) Donor in Hospitalized Patients With Heart FailureA Study to Evaluate Safety and Efficacy of Continuous 48-Hour Intravenous Infusions of HNO Donor in Hospitalized Patients with Heart Failure and Impaired Systolic FunctionNCT03016325·Tucson, Arizona and 115 others

CompletedA Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe SepsisThe purpose of this study is to determine whether the administration of the study drug is effective in increasing the chance of survival in patients with severe sepsis.NCT00034476·Birmingham, Alabama and 84 others

CompletedPhase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid LeukemiaThere are 2 parts to this study: Part 1 (dose escalation) and Part 2 (dose expansion).NCT02530476·Houston, Texas

TerminatedTiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)The primary objectives of this study are to assess bronchodilator efficacy as determined by forced expiratory volume in one second (FEV1), the effect on dyspnoea as determined by…NCT00662740·Boulder, Colorado and 71 others

CompletedA Trial In Patients With Advanced Cancer And LeukemiaThis is a phase 1, dose escalating study to determine the safety of PF-03084014 in patients with advanced cancer and leukemiaNCT00878189·Aurora, Colorado and 9 others

PreviousPage 234 of 1125Next

in Houston

Heart Diseasein Houston